Selected Papers and Presentations

The Ethics of Controlling Drug Prices in the United States, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 23, 2024.

AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc., presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 18, 2023.

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, January 31 and February 7, 2023.

Compassionate Use, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 26, 2022.

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, February 1 and 8, 2022.

Biotechnology and Pharmaceutical Law, presented as part of the Industry 101 Series hosted by the GSAS Harvard Biotech Club, Boston, Massachusetts, October 21, 2021.

The Ethics of Authorized Generic Drug Sales During the ANDA Exclusivity Period, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 13, 2021.

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, March 2 and 9, 2021.

Breaking Drug Patents in the Time of COVID-19, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 28, 2020.

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, April 7 and 14, 2020.

Ethics and the New GMO Labeling Law, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 30, 2019.

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, January 22 and 29, 2019.

Ethics and pharmaceutical product hopping, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 18, 2018.

Patent aspects of biotechnology investment, presented at Rockefeller University and hosted by the Tri-Institutional Biotech Club (Weill Cornell Medical Center, Memorial Sloan Kettering Cancer Center and Rockefeller University), New York, New York, March 29, 2018.

The Biotechnology Patent: Today's Challenges, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 2, 2017, and January 30, 2018.

Patent Inventorship and Infringement, presented in two parts as part of the intellectual property course at the Icahn School of Medicine at Mount Sinai, New York, New York, September 19 and 26, 2017.

Lowering drug prices by shorting drug companies' stocks while attacking their patents - public service or ethical breach?, presented as part of the Global Bioethics course, New York University, New York, New York, May 2, 2017.

Short selling a drug company's stock in conjunction with challenging its drug patents through inter partes review, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 19, 2017.

After AMP v. Myriad - Using trade secret protection for genetic testing innovations, presented at Weill Cornell Medical College and hosted by the Weill Cornell Biotech Club, New York, New York, November 7, 2016.

Patent Inventorship in the United States, and Why It Matters, Third Annual Conference of the Sino-American Pharmaceutical Professionals Association - Connecticut, co-organized by the Association of Chinese Students and Scholars at Yale and the Chinese Association for Science and Technology, New Haven, Connecticut, October 8, 2016.

The ethics of maintaining a patient's genetic information as a trade secret: the case of Myriad Genetics' human BRCA VUS database, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 27, 2016.

Biotechnology Patents and the Latest Drama, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 9, 2016.

Hey! That's my invention! Why inventorship matters in U.S. patent law, and what happens when we get it wrong, presented at Weill Cornell Medical College and hosted by the Weill Cornell Biotech Club, New York, New York, September 24, 2015.

The Supreme Court’s Myriad and Prometheus Decisions, and Their Effect on Healthcare, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 29, 2015.

Filing Your First Biotech Patent Application: Strategies for Startups – Part 2, presented at Harlem Biospace, New York, New York, February 23, 2015.

Biotechnology, Patents, and the FDA, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 29, 2015.

Filing Your First Biotech Patent Application: Strategies for Startups – Part 1, presented at Harlem Biospace, New York, New York, November 17, 2014.

The U.S. Supreme Court’s AMP v. Myriad Decision, and its Ethical Implications, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 25, 2014.

Protecting Biotechnology in an Era of Judicial Hostility, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 30, 2014.

Alan J. Morrison and Richard T. Ruzich, Gunn v. Minton and the Patent Malpractice Case, Intellectual Property Magazine, October 2013, 62-63.

Alan J. Morrison, Supreme Court's Myriad Decision on Patenting Isolated DNA, Cozen O'Connor Intellectual Property Alert, June 17, 2013.

The Ethics of Reverse Payment Agreements Between Brand Name and Generic Drug Companies Under the Hatch-Waxman Act and The U.S. Supreme Court and the Future of Human Gene Patents, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, April 24, 2013.

Alan J. Morrison, Protecting Your Patents by Getting Inventorship Right, Cozen O’Connor Business Law Observer, Winter 2013.

Protecting Biotechnology Inventions, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, January 31, 2013.

The U.S. Patent: An Update, presented at the Beijing Foreign Studies University Law School, Beijing, China, April 9, 2012.

Biotechnology Patent Protection in the United States, presented at the Seminar on Special Topics in Exploring Anhui Province’s Corporate Investment and Development Opportunities in the United States, held under the auspices of the Anhui Provincial Government’s Development Research Center, Hefei City, Anhui Province, China, April 7, 2012.

The Ethics of DNA Patents and Pay-for-Delay Schemes, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, February 8, 2012.

Intellectual Property Law for Biotechnology, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 2, 2012.

The New Waiting Game: Biosimilar Drugs and the 12-Year Exclusivity Period, presented as part of the Symposium on Access to Essential Medicines, Biotechnology Patents, and Global Cooperation, Temple University, Beasley School of Law, Philadelphia, Pennsylvania, April 1, 2011.

The Bioethics of Gene Patents, presented as part of the Ethics for Biomedical Engineering course, Columbia University, New York, New York, February 16, 2011.

Special Topics in Biotechnology Law, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 8, 2011.

Introduction to Intellectual Property for the Biosciences, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 3, 2011.

Alan J. Morrison, Rethinking the Gene Patent, Biotechnology Law Report. December 2010, 29(6): 609-614.

Podcast interview of Alan J. Morrison by Doris Gilman of Health Thought Leadership One-to-One, November 1, 2010, providing an introduction to the topic of gene patents.

IP Issues in the Therapeutic Antibody Industry (Chapter 39 of Antibody Engineering), United States subchapter of Patent Enforcement (39.4.13), Springer-Verlag Berlin Heidelberg, 2010 (Contributor).

Should Genes Be Patented?, a panel discussion with Dr. Wendy Chung, Alan J. Morrison, Esq. and Dr. John Loike, presented at Columbia University and hosted by Columbia Technology Ventures, New York, New York, April 28, 2010 (Panelist).

Challenging the Biotech Patent: The ACLU Takes on Myriad Genetics and the U.S. Patent Office, presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 9, 2010.

What Price Biosimilars? Balancing the Innovation and Cost of Biologics in America, presented at Biologic India 2009, Mumbai, India, December 2, 2009.

Understanding the U.S. Biotechnology Patent, presented at Sun Yat-Sen University, Guangzhou, China, June 16, 2009.

Selected Developments in U.S. Biotech Patent Law - 2009, presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Partner, Düsseldorf, Germany, May 5, 2009.

Understanding the Biotechnology Patent, presented to the Master’s Program in Biotechnology, Columbia University, New York, New York, March 11, 2009.

Ethical Issues Concerning Human Embryonic Stem Cell Patents, presented at the second annual meeting of The Stem Cell Partnering Series, held at the University of California, San Diego, La Jolla, California, February 27, 2009 (Meeting Co-Chair).

Selected Thoughts on Legal Writing in Patent Law, presented to The Scientific Patent Law Group in New York and The New York Academy of Sciences, held at The New York Academy of Sciences, New York, New York, February 19, 2009.

Alan J. Morrison, Patenting DNA in the United States, Managing Intellectual Property (December 2008/January 2009).

Legal Hurdles and Strategies in Building a University Biotech Portfolio, presented as part of the panel on Building a Strong University Biotech Patent Portfolio, held at the 2008 Life Sciences Industry Summit, Long Island, New York, June 5, 2008 (Panel Chair).

Selected Topics in U.S. Biotech Patent Law, presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Partner, Düsseldorf, Germany, May 16, 2008.

Panel on Patenting Stem Cells at the Inaugural Conference on Fostering Business Collaboration & Careers in Stem Cell Science, hosted by the Stem Cell Partnering Series at U.C. San Diego, La Jolla, California, February 29, 2008 (Moderator).

Biosimilars in the United States: An Update, presented at Biosimilars 2007 organized by Visiongain, London, United Kingdom, December 6, 2007.

Alan J. Morrison, Biosimilars in the United States: A Brief Look at Where We Are and the Road Ahead, Biotechnology Law Report. October 2007, 26(5): 463-468.

Understanding, Prosecuting and Enforcing Biotech and Pharmaceutical Patents in the United States, presented at the 2007 IP Workshop for Biotech Pharmaceutical Industry (Including Generic Drug Entry in the US), held under the auspices of the Center for Drug Evaluation, Taipei, Taiwan, April 2, 2007.

Trade Secret Protection: When and How It Should Be Used, presented at Effective Corporate IP Programs organized by Law Seminars International, Atlanta, Georgia, December 1, 2005 (Co-Author).

Double Patenting, presented at the Eighteenth Annual Pharmaceutical/Chemical Patent Practice Update sponsored by the New Jersey Intellectual Property Law Association, Committee on Chemical Practice, Iselin, New Jersey, December 9, 2004 (Co-Author).

U.S. Biotechnology and Pharmaceutical Law, an introductory lecture series presented as part of the Recovering Nations Project, and co-hosted by the Freetown law firm of Roberts & Partners, Freetown, Sierra Leone, November 22-24, 2004 (Co-Developer).

Non-Patent Protection for Biopharmaceuticals, presented at Biopharmaceuticals: Running the Race from Drug Discovery to Commercialization organized by Law Seminars International, Raleigh, North Carolina, May 3, 2004 (Co-Author).

Determining Inventorship Under United States Patent Law, presented at the Conference on Protection of Intellectual Property Rights sponsored by the Center for International Legal Studies, Kitzbühel, Austria, March 15, 2004.

Non-Patent Protection for Biotechnology and Pharmaceuticals, presented at Biotechnology from Start to Finish organized by Law Seminars International, San Diego, California, March 8, 2004 (Co-Author).

Claim Drafting Workshop: Chemical/Biotechnology, held as part of the American Intellectual Property Law Association's Patent Prosecution Training for New Lawyers, Washington, DC, August 15, 2003 (Workshop Co-Chair).

Determining Inventorship, presented at the Sixteenth Annual Pharmaceutical/Chemical Patent Practice Update sponsored by the New Jersey Intellectual Property Law Association, Committee on Chemical Practice, Iselin, New Jersey, December 12, 2002 (Co-Author).

Claim Drafting Workshop: Chemical/Biotechnology, held as part of the American Intellectual Property Law Association’s Patent Prosecution Basic Training, Washington, DC, August 24, 2002, August 17, 2001 and September 21, 2000.

Intellectual Property Aspects of Mergers and Acquisitions, presented as part of a course on International Mergers and Acquisitions, New York University, July 31 and November 9, 2000.

An Overview of Pharmaceutical Patent Practice in the United States, presented at the Symposium on Intellectual Property and the Internationalization of Chinese Medicinal Products, Hong Kong Baptist University, Hong Kong, May 17-19, 1999.

Selected Topics in U.S. Pharmaceutical Patent Practice, hosted by the U.S.-China Intellectual Property Institute, Hong Kong Baptist University, Hong Kong, December 23, 1998.

Advanced Training Course in U.S. Pharmaceutical Patent Practice, held under the auspices of the Ministry of Technology, Guangzhou, China, September 21-25, 1998 (Co-Developer).